Lataa...
Fulvestrant: pharmacokinetics and pharmacology
Fulvestrant is a new type of oestrogen receptor (ER) antagonist with no agonist activity and a novel pharmacological profile. Fulvestrant has been shown to significantly reduce cellular levels of the ER and progesterone receptor in both preclinical studies and in clinical trials of postmenopausal wo...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2004
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2750771/ https://ncbi.nlm.nih.gov/pubmed/15094758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601630 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|